Shanghai Pharmaceuticals Holding Co Ltd (601607) — Financial Flexibility Index
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥2.05 Billion (operating CF CN¥1.56 Billion minus capex CN¥487.63 Million) represents 0% of total liabilities (CN¥147.12 Billion). Also explore Shanghai Pharmaceuticals Holding Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. Check Shanghai Pharmaceuticals Holding Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Shanghai Pharmaceuticals Holding Co Ltd. For the full company profile including market capitalisation, see 601607 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥8.48 Billion | CN¥6.15 Billion | CN¥143.36 Billion | ▼ -1.2% |
| 2024 | 0.06x | CN¥8.23 Billion | CN¥5.83 Billion | CN¥137.47 Billion | ▼ -3.9% |
| 2023 | 0.06x | CN¥8.20 Billion | CN¥5.23 Billion | CN¥131.65 Billion | ▲ +0.8% |
| 2022 | 0.06x | CN¥7.43 Billion | CN¥4.74 Billion | CN¥120.13 Billion | ▼ -29.7% |
| 2021 | 0.09x | CN¥9.18 Billion | CN¥5.06 Billion | CN¥104.37 Billion | ▼ -15.7% |
| 2020 | 0.10x | CN¥9.85 Billion | CN¥6.84 Billion | CN¥94.44 Billion | ▲ +4.2% |
| 2019 | 0.10x | CN¥8.78 Billion | CN¥6.02 Billion | CN¥87.64 Billion | ▲ +58.6% |
| 2018 | 0.06x | CN¥5.08 Billion | CN¥3.14 Billion | CN¥80.45 Billion | ▼ -25.9% |
| 2017 | 0.09x | CN¥4.66 Billion | CN¥2.65 Billion | CN¥54.67 Billion | ▼ -3.8% |
| 2016 | 0.09x | CN¥4.07 Billion | CN¥1.95 Billion | CN¥45.91 Billion | ▲ +17.0% |
| 2015 | 0.08x | CN¥3.07 Billion | CN¥1.35 Billion | CN¥40.54 Billion | ▼ -4.2% |
| 2014 | 0.08x | CN¥2.63 Billion | CN¥1.34 Billion | CN¥33.24 Billion | ▲ +14.9% |
| 2013 | 0.07x | CN¥1.88 Billion | CN¥973.45 Million | CN¥27.31 Billion | ▼ -13.6% |
| 2012 | 0.08x | CN¥1.86 Billion | CN¥1.15 Billion | CN¥23.37 Billion | ▼ -21.0% |
| 2011 | 0.10x | CN¥2.19 Billion | CN¥1.77 Billion | CN¥21.69 Billion | ▼ -26.6% |
| 2010 | 0.14x | CN¥2.24 Billion | CN¥1.69 Billion | CN¥16.28 Billion | ▲ +16.9% |
| 2009 | 0.12x | CN¥744.10 Million | CN¥664.13 Million | CN¥6.33 Billion | ▲ +76.9% |
| 2008 | 0.07x | CN¥376.18 Million | CN¥285.68 Million | CN¥5.67 Billion | ▼ -49.6% |
| 2007 | 0.13x | CN¥681.23 Million | CN¥488.94 Million | CN¥5.17 Billion | ▼ -17.3% |
| 2006 | 0.16x | CN¥734.71 Million | CN¥583.11 Million | CN¥4.61 Billion | ▲ +156.8% |
| 2005 | 0.06x | CN¥271.09 Million | CN¥73.00 Million | CN¥4.37 Billion | ▼ -13.6% |
| 2004 | 0.07x | CN¥316.05 Million | CN¥61.66 Million | CN¥4.40 Billion | ▲ +70.0% |
| 2003 | 0.04x | CN¥170.07 Million | CN¥484.27K | CN¥4.03 Billion | ▼ -62.2% |
| 2002 | 0.11x | CN¥380.28 Million | CN¥100.84 Million | CN¥3.40 Billion | ▲ +31.4% |
| 2001 | 0.09x | CN¥210.44 Million | CN¥65.73 Million | CN¥2.47 Billion | ▼ -24.5% |
| 2000 | 0.11x | CN¥287.31 Million | CN¥146.22 Million | CN¥2.55 Billion | ▲ +14.4% |
| 1999 | 0.10x | CN¥217.15 Million | CN¥164.67 Million | CN¥2.21 Billion | ▲ +265.0% |
| 1998 | -0.06x | CN¥-113.25 Million | CN¥-283.14 Million | CN¥1.90 Billion | — |